Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
525,2 USD | +3,19% | +4,63% | +11,37% |
18/04 | ELEVANCE HEALTH, INC. : Cantor Fitzgerald handhaaft koopadvies | ZM |
18/04 | ELEVANCE HEALTH, INC. : Stephens Inc. bevestigt koopadvies | ZM |
Omzet 2024 * | 171 mld. 161 mld. | Omzet 2025 * | 182 mld. 171 mld. | Marktkapitalisatie | 122 mld. 115 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,92 mld. 7,44 mld. | Nettowinst (verlies) 2025 * | 9,1 mld. 8,55 mld. | EV/omzet 2024 * | 0,8 x |
Nettoschuld 2024 * | 14,36 mld. 13,5 mld. | Nettoschuld 2025 * | 10,89 mld. 10,24 mld. | EV/omzet 2025 * | 0,73 x |
K/w-verhouding 2024 * |
15,6
x | K/w-verhouding 2025 * |
13,4
x | Werknemers | 104.900 |
Dividendrendement 2024 * |
1,19% | Dividendrendement 2025 * |
1,27% | Vrij verhandelbaar | 99,55% |
Recentste transcriptie over Elevance Health, Inc.
1 dag | +3,19% | ||
1 week | +4,63% | ||
Lopende maand | +1,28% | ||
1 maand | +2,72% | ||
3 maanden | +11,90% | ||
6 maanden | +11,91% | ||
Lopend jaar | +11,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20-11-17 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 06-09-23 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | 05/02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 74 | 01-10-13 | |
Director/Board Member | 55 | 01-11-22 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20-11-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
3.22% | 18 M€ | +2,91% | - | |
2.36% | 1 026 M€ | +6,11% | - | |
2.07% | 8 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 525,2 | +3,19% | 2 584 713 |
17-04-24 | 509 | +0,39% | 1 401 591 |
16-04-24 | 507 | +1,38% | 1 127 280 |
15-04-24 | 500,1 | +0,52% | 1 031 789 |
12-04-24 | 497,5 | -0,89% | 1 188 685 |
uitgestelde koers Nyse, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,37% | 118 mld. | |
+16,47% | 98,16 mld. | |
-29,05% | 38,99 mld. | |
-0,62% | 38,51 mld. | |
-0,10% | 21,08 mld. | |
-14,25% | 3,15 mld. | |
-40,53% | 935 mln. | |
-33,71% | 308 mln. |